April 24, 2024 | |
Name of listed company: Chugai Pharmaceutical Co., Ltd. | |
Code number: | 4519 (Prime Market of Tokyo Stock Exchange) |
Head office: | 1-1,Nihonbashi-Muromachi2-Chome,Chuo-ku, Tokyo |
President & CEO: | Osamu Okuda |
Inquiries to: | Kae Miyata |
Head of Corporate Communications Dept. | |
Tel: +81-(0)3-3273-0554 |
F. Hoffmann-La Roche Announces First Quarter Sales 2024
F. Hoffmann-La Roche Ltd (hereafter "Roche") [Head Office: Basel, Switzerland. CEO: Thomas Schinecker] announced today its first quarter sales 2024 (January 1 - March 31, 2024).
Roche Holding Ltd is a parent company of Roche and Chugai. The Company owns 59.89% of Chugai's issued shares (61.13% of voting rights) as of the end of December 2023.
Its investor update and presentation materials can be found on its website (https://www.roche.com).
Chugai's performance for the period of January 1 to March 31, 2024 is included in the announced Roche Group's results.
Investor Updates | Reporting |
###
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Chugai Pharmaceutical Co. Ltd. published this content on 24 April 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 24 April 2024 05:05:22 UTC.